Clinical and angiographic outcome of sirolimus-eluting stent for the treatment of very long lesions

Korean Circulation Journal

Volumn 36, Issue 7, 2006, Pages 490-494

  Park, Jong Seon ^a   Kim, Young Jo ^a   Shin, Dong Gu ^a   Shim, Bong Sup ^a   Hong, Gu Ru ^a   Bae, Jun Ho ^a   Nam, Chang Wook ^b   Hur, Seung Ho ^b   Han, Seong Wook ^b   Kim, Kee Sik ^b   Kim, Yoon Nyun ^b   Kim, Kwon Bae ^b   Kim, Doo Il ^c   Kim, Dae Kyung ^c   Kim, Seong Man ^c   Yang, Tae Hyun ^c   Kim, Dong Soo ^c  

^a Yeungnam University College of Medicine   (South Korea)

^b Keimyung University   (South Korea)

^c Inje University College of Medicine   (South Korea)

Author keywords

Outcome; Percutaneous coronary angioplasty; Stents

Indexed keywords

CREATINE KINASE MB; RAPAMYCIN;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; SUDDEN DEATH; THROMBOSIS; TREATMENT OUTCOME; VASCULAR LESION;

EID: 33747770289     PISSN: 17385520     EISSN: 17385555     Source Type: Journal    
DOI: 10.4070/kcj.2006.36.7.490     Document Type: Article

References (20)

1. Schofer J, Schluter M, Gershlick AH, et al. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS). Lancet 2003;362:1093-9.
2. Holmes DR Jr, Leon MB, Moses JW, et al. Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis. Circulation 2004;109:634-40.
3. Schofer J. Lessons from the E-SIRIUS trial. Ital Mean J 2004;5: 1-2.
4. Ajani AE, Waksman R, Cha DH, et al. The impact of lesion length and reference vessel diameter on angiographic restenosis and target vessel revascularization in treating in-stent restenosis with radiation. J Am Coll Cardiol 2002;39:1290-6.
5. Pan M, Suarez de Lezo J, Medina A, et al. Influence of stent treatment strategies in the long-term outcome of patients with long diffuse coronary lesions. Catheter Cardiovasc Interv 2003;58: 293-300.
6. Mehran R, Dangas G, Abizaid AS, et al. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation 1999;100:1872-8.
7. Prieto AR, Przybysz A, Fischell TA. Long balloon angioplasty with focal stenting for the treatment of diffuse coronary artery disease. Catheter Cardiovasc Interv 2002;57:437-43.
8. le Breton H, Bedossa M, Commeau P, et al. Clinical and angiographic results of stenting for long coronary arterial atherosclerotic lesions. Am J Cardiol 1998;82:1539-43, A8.
9. Ruiz-Nodar JM, Erutos A, Carrillo P, et al. Use of simlimus-eluting stents in complex lesions: clinical and angiographic follow-up. Rev Esp Cardiol 2004;57:123-9.
10. Aoki J, Ong AT, Rodriguez Granillo GA, et al. "Full metal jacket" (stented length > or =64 mm) using drug-eluting stents for de novo coronary artery lesions. Am Heart J 2005;150:994-9.
11. Kobayashi Y, de Gregorio J, Kobayashi N, et al. Stented segment length as an independent predictor of restenosis. J Am Coll Cardiol 1999;34:651-9.
12. Murphy GJ, Bicknell GR, Nicholson ML. The effect of combined rapamycin/cyclosporine on the changes in pro-fibrotic gene expression that occur during the development of allograft vasculopathy in rats, compared with cyclosporine or rapamycin in isolation. Transpl Int 2003;16:347-53.
13. Colombo A, de Gregorio J, Moussa I, et al. Intravascular ultrasound-guided percutaneous transluminal coronary angioplasty with provisional spot stenting for treatment of long coronary lesions. J Am Coll Cardiol 2001;38:1427-33.
14. Farb A, Heller PF, Shroff S, et al. Pathological analysis of local delivery of paclitaxel via a polymer-coated stent. Circulation 2001;104:473-9.
15. Park DW, Park SW. Stent thrombosis in the era of the drug-eluting stent. Korean Circ J 2005;35:791-4.
16. Decoene C, Vincentelli A, Fabre O, Crepin F, Pol A. Late thrombosis of a drug-eluting coronary stent after antiplatelet therapy discontinuation. Ann Fr Anesth Reanim 2005;24:1275-7.
17. Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005;293:2126-30.
18. Karvouni E, Korovesis S, Katritsis DG. Very late thrombosis after implantation of sirolimus elating stent. Heart 2005;91:e45.
19. Ge J, Han Y, Jiang H, et al. RACTS: a prospective randomized antiplatelet trial of cilostazol versus ticlopidine in patients undergoing coronary stenting: long-term clinical and angiographic outcome. J Cardiovasc Pharmacol 2005;46:162-6.
20. Byun KH, Shim JK, Min SJ, Jeon SJ, Kim JH. The multiple combined oral platelet aggregation Inhibitors of aspirin, ticlopidine and cilostazol after PCI. Korean Circ J 2004;34:443-50.